ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: The current study highlights a unique role for Gadd45a as a tumor suppressor in BCR-ABL driven leukemogenesis, characterized by its’ loss causing an increase in the number and self-renewal capability of CML cells (Figure 4D).